FAKTOR OPTIONSSCHEIN - STRYKER CORP. Stock

Certificat

DE000GQ2Y407

Market Closed - Bid/Ask 08:27:12 2024-06-19 EDT After market 11:23:50
4.57 EUR +9.86% Intraday chart for FAKTOR OPTIONSSCHEIN - STRYKER CORP. 4.675 +2.30%
Current month+27.61%
1 month+44.44%
Date Price Change
24-06-19 4.57 +9.86%
24-06-18 4.16 +10.34%
24-06-17 3.77 +5.31%
24-06-14 3.58 +0.28%
24-06-13 3.57 -17.36%

Real-time BOERSE MUENCHEN

Last update June 19, 2024 at 08:27 am

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Goldman Sachs
WKN GQ2Y40
ISINDE000GQ2Y407
Date issued 2023-08-24
Strike 318.2 $
Maturity Unlimited
Parity 6.65 : 1
Emission price 8.52
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 21.39
Lowest since issue 1.03
Spread 0.07
Spread %1.49%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus